Nvwm, LLC Viatris Inc Transaction History

Nvwm, LLC

$380 Million
Q4 2024

A detailed history of Nvwm, LLC transactions in Viatris Inc stock. As of the latest transaction made, Nvwm, LLC holds 20 shares of VTRS stock, worth $225. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 23 13.04%

Holding current value

$225

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$11.32 - $13.37 $33 - $40	-3 Reduced 13.04%	20 $0
Q2 2024 Aug 13, 2024	SELL	$10.05 - $12.02 $361 - $432	-36 Reduced 61.02%	23 $0
Q1 2024 May 06, 2024	BUY	$11.27 - $13.53 $473 - $568	42 Added 247.06%	59 $0
Q3 2023 Oct 30, 2023	SELL	$9.59 - $11.35 $38 - $45	-4 Reduced 19.05%	17 $0
Q2 2022 Aug 04, 2022	SELL	$9.95 - $12.27 $1,522 - $1,877	-153 Reduced 87.93%	21 $0
Q1 2022 May 11, 2022	BUY	$9.81 - $15.4 $1,500 - $2,356	153 Added 728.57%	174 $2,000
Q4 2021 Feb 08, 2022	SELL	$12.09 - $14.68 $2,152 - $2,613	-178 Reduced 89.45%	21 $0
Q3 2021 Nov 03, 2021	SELL	$13.25 - $15.13 $39 - $45	-3 Reduced 1.49%	199 $3,000
Q1 2021 May 11, 2021	SELL	$13.59 - $18.54 $34,967 - $47,703	-2,573 Reduced 92.72%	202 $3,000
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $39,682 - $52,003	2,775 New	2,775 $52,000

Others Institutions Holding VTRS

# of Institutions

1,095

Shares Held

965M

Call Options Held

2.69M

Put Options Held

2.34M

Vanguard Group Inc Valley Forge, PA

141M
Shares

$1.59 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

92.7M
Shares

$1.05 Billion
0.02% of portfolio
State Street Corp Boston, MA

63.1M
Shares

$712 Million
0.03% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

62.6M
Shares

$707 Million
4.18% of portfolio
Price T Rowe Associates Inc Baltimore, MD

48.8M
Shares

$550 Million
0.07% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.

Account